{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:19:03Z","timestamp":1778249943638,"version":"3.51.4"},"reference-count":68,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multidrug-resistant tuberculosis (MDR-TB) is a constraining challenge for tuberculosis (TB) control worldwide. The Middle East and North African (MENA) region represents a significant part of the global MDR-TB burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To estimate the pooled prevalence of MDR-TB and its determinants in the MENA region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched for studies published in English and French on the subject up to 31 January 2026 on Web of Science, PubMed, Scopus and Cochrane, without time restriction. Original studies reporting data on the prevalence of MDR-TB in individuals living in the MENA region were selected. The meta-analysis was done using the random effects model considering the heterogeneity among the included studies and\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      statistic was used to assess the heterogeneity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1239 articles were identified and 25 studies from 6 countries were included in this review. The prevalence of MDR-TB in the MENA region ranged from 0% (95% CI 0% to 4.1%) to 17.1% (95% CI 10.6% to 25.4%). The pooled prevalence was 3.54% (95% CI 2.18% to 5.72%) with a high heterogeneity,\n                      <jats:italic>\n                        I\n                        <jats:sup>2<\/jats:sup>\n                      <\/jats:italic>\n                      =95.6%; 95% CI 94.4% to 96.5%. Previous exposition to TB treatment, HIV infection, smoking and the presence of comorbidities were the most reported associated factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review underscores the persistence of MDR-TB in the MENA region, suggesting insufficiency in TB control. Multisectoral interventions integrating strong prevention measures, standardised treatment protocols and measures to enhance treatment adherence should be implemented.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003887","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:06:10Z","timestamp":1778249170000},"page":"e003887","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and determinants of drug-resistant pulmonary tuberculosis in the MENA region: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4507-3265","authenticated-orcid":false,"given":"Oumar Abakar","family":"Mahamed","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Department of Epidemiology, Clinical Research and Community Health, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9944-2670","authenticated-orcid":false,"given":"Noussissy Sandokane","family":"Hounnoukon","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Department of Epidemiology, Clinical Research and Community Health, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5285-0099","authenticated-orcid":false,"given":"Soraya","family":"Laraqui Houssaini","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Department of Epidemiology, Clinical Research and Community Health, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7808-6128","authenticated-orcid":false,"given":"Imane","family":"El Faziki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Department of Epidemiology, Clinical Research and Community Health, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2892-0355","authenticated-orcid":false,"given":"Meryeme","family":"Kirat","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Department of Epidemiology, Clinical Research and Community Health, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-9044","authenticated-orcid":false,"given":"Karima","family":"El Rhazi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Department of Epidemiology, Clinical Research and Community Health, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, Morocco"},{"name":"Faculty of Medicine, Pharmacy and Dental Medicine, Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"2026050807051672000_13.1.e003887.1","unstructured":"Tuberculosis (TB), WHO Regional office for africa. 2025. Available: https:\/\/www.afro.who.int\/health-topics\/tuberculosis-tb [Accessed 10 Feb 2025]."},{"key":"2026050807051672000_13.1.e003887.2","unstructured":"Tuberculose. Available: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/tuberculosis [Accessed 10 Feb 2025]."},{"key":"2026050807051672000_13.1.e003887.3","unstructured":"R\u00e9sistance aux antimicrobiens. Available: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/antimicrobial-resistance [Accessed 10 Feb 2025]."},{"key":"2026050807051672000_13.1.e003887.4","unstructured":"Drug-resistant tb. Available: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024\/tb-disease-burden\/1-3-drug-resistant-tb [Accessed 15 Apr 2025]."},{"key":"2026050807051672000_13.1.e003887.5","unstructured":"Tuberculosis epidemiological situation in the the WHO Eastern Mediterranean Region . World health organization - regional office for the eastern mediterranean. Available: http:\/\/www.emro.who.int\/tuberculosis\/epidemiological-situation\/index.html [Accessed 23 Feb 2025]."},{"key":"2026050807051672000_13.1.e003887.6","unstructured":"SDGs: sustainable development knowledge platform. Available: https:\/\/sustainabledevelopment.un.org\/topics\/sustainabledevelopmentgoals [Accessed 10 Feb 2025]."},{"key":"2026050807051672000_13.1.e003887.7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4314\/ahs.v23i3.43","article-title":"Epidemiological features of tuberculosis in the Middle East and North Africa from 1990 to 2019: results from the global burden of disease Study 2019","volume":"23","author":"Moradinazar","year":"2023","journal-title":"Afr Health Sci"},{"key":"2026050807051672000_13.1.e003887.8","unstructured":"Tuberculosis: multidrug-resistant (MDR-TB) or rifampicin-resistant TB (RR-TB). Available: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb) [Accessed 20 Apr 2025]."},{"key":"2026050807051672000_13.1.e003887.9","first-page":"585","article-title":"Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia","volume":"6","author":"Singla","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026050807051672000_13.1.e003887.10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/14787210.2019.1689818","article-title":"Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications","volume":"17","author":"Ali","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026050807051672000_13.1.e003887.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153983","article-title":"MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years","volume":"11","author":"Dekhil","year":"2016","journal-title":"PLoS One"},{"key":"2026050807051672000_13.1.e003887.12","first-page":"750","article-title":"Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006","volume":"12","author":"Masjedi","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026050807051672000_13.1.e003887.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73209-x","article-title":"Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient\u2019s record data from 2016 to 2021: retrospective study","volume":"14","author":"Wotale","year":"2024","journal-title":"Sci Rep"},{"key":"2026050807051672000_13.1.e003887.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026050807051672000_13.1.e003887.15","unstructured":"World Health Organization . Definitions and reporting framework for tuberculosis \u2013 2013 revision: updated december 2014 and january 2020. Geneva World Health Organization; 2013."},{"key":"2026050807051672000_13.1.e003887.16","unstructured":"Martin J . Joanna Briggs Institute 2017: Critical Appraisal Checklist for Prevalence Studies. 2017."},{"key":"2026050807051672000_13.1.e003887.17","unstructured":"R: the R project for statistical computing. Available: https:\/\/www.r-project.org\/ [Accessed 17 Mar 2025]."},{"key":"2026050807051672000_13.1.e003887.18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.34172\/aim.2022.27","article-title":"A Report on Drug Resistance Patterns of Mycobacterium tuberculosis Isolates in Northern Iran","volume":"25","author":"Mansoori","year":"2022","journal-title":"Arch Iran Med"},{"key":"2026050807051672000_13.1.e003887.19","doi-asserted-by":"crossref","unstructured":"Bayat S , Gol-Mohamadi A , Sarbazi MR , et al . A Seven Year Retrospective Study on Epidemiology and Clinical Characteristics of Tuberculosis in Iran. Arch Clin Infect Dis 2013;8. doi:10.5812\/archcid.14505","DOI":"10.5812\/archcid.14505"},{"key":"2026050807051672000_13.1.e003887.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/747085","article-title":"Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013","volume":"2015","author":"Tavanaee Sani","year":"2015","journal-title":"Biomed Res Int"},{"key":"2026050807051672000_13.1.e003887.21","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4103\/jfmpc.jfmpc_983_19","article-title":"Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it\u2019s risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017","volume":"9","author":"Salmanzadeh","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"2026050807051672000_13.1.e003887.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-022-01425-7","article-title":"Genetic diversity of drug-resistant Mycobacterium tuberculosis clinical isolates from Khuzestan province, Iran","volume":"12","author":"Bakhtiyariniya","year":"2022","journal-title":"AMB Express"},{"key":"2026050807051672000_13.1.e003887.23","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0057"},{"key":"2026050807051672000_13.1.e003887.24","doi-asserted-by":"crossref","unstructured":"Khelghati F , Nasirpour Seilakhori F , Goudarzi M , et al . Multidrug-resistant tuberculosis in Iran: a multicenter study. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. Published Online First 2024. doi:10.4081\/monaldi.2024.2844","DOI":"10.4081\/monaldi.2024.2844"},{"key":"2026050807051672000_13.1.e003887.25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874306401610010029","article-title":"Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran","volume":"10","author":"Sahebi","year":"2016","journal-title":"Open Respir Med J"},{"key":"2026050807051672000_13.1.e003887.26","first-page":"193","article-title":"The Pattern of Tuberculosis in Iran: A National Cross-Sectional Study","volume":"52","author":"Doosti","year":"2023","journal-title":"Iran J Public Health"},{"key":"2026050807051672000_13.1.e003887.27","first-page":"190","article-title":"Prevalence of pulmonary tuberculosis before and after soil dust in Khuzestan, southwest Iran","volume":"5","author":"Alavi","year":"2014","journal-title":"Caspian J Intern Med"},{"key":"2026050807051672000_13.1.e003887.28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02403-12"},{"key":"2026050807051672000_13.1.e003887.29","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2021.42.6.20200832"},{"key":"2026050807051672000_13.1.e003887.30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/ecdt.ecdt_113_22","article-title":"Prevalence and risk factors of multidrug-resistant tuberculosis in Jazan, Saudi Arabia","volume":"72","author":"Abdelfattah","year":"2023","journal-title":"ECDT"},{"key":"2026050807051672000_13.1.e003887.31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15537\/1658-3175.1648","article-title":"Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia","volume":"23","author":"Alrajhi","year":"2002","journal-title":"Saudi Med J"},{"key":"2026050807051672000_13.1.e003887.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1167-4"},{"key":"2026050807051672000_13.1.e003887.33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.3.738"},{"key":"2026050807051672000_13.1.e003887.34","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1196904","article-title":"Genomic, phenotypic and demographic characterization of Mycobacterium tuberculosis in Israel in 2021","volume":"13","author":"Losev","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2026050807051672000_13.1.e003887.35","doi-asserted-by":"publisher","DOI":"10.1089\/107662903322762798"},{"key":"2026050807051672000_13.1.e003887.36","first-page":"2304","article-title":"Primary resistance rates of Mycobacterium tuberculosis complex strains isolated from new tuberculosis cases: A 6-year observation","volume":"5","author":"Kayhan","year":"2011","journal-title":"African journal of microbiology research"},{"key":"2026050807051672000_13.1.e003887.37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7883\/yoken.JJID.2005.47","article-title":"The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey","volume":"58","author":"Ozturk","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"2026050807051672000_13.1.e003887.38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4314\/sjms.v6i2.72462","article-title":"A study on Prevalence of Drug Resistance in Drug Default Pulmonary Tuberculosis","volume":"6","author":"Zaki","year":"2011","journal-title":"Sud Jnl Med Sci"},{"key":"2026050807051672000_13.1.e003887.39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/ijmy.ijmy_82_18","article-title":"Molecular characterization of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Khartoum, Sudan","volume":"7","author":"Elegail","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"2026050807051672000_13.1.e003887.40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijid.2008.10.006","article-title":"Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis","volume":"13","author":"Abbadi","year":"2009","journal-title":"Int J Infect Dis"},{"key":"2026050807051672000_13.1.e003887.41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/IJGM.S494516","article-title":"Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia","volume":"18","author":"Mokhtar","year":"2025","journal-title":"Int J Gen Med"},{"key":"2026050807051672000_13.1.e003887.42","first-page":"1060","article-title":"Resistance Rates of Mycobacterium tuberculosis Complex Strains: A Retrospective Study in T\u00fcrkiye","volume":"61","author":"Payasl\u0131o\u011flu","year":"2025","journal-title":"Med Bogota Colomb"},{"key":"2026050807051672000_13.1.e003887.43","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infect Dis Poverty"},{"key":"2026050807051672000_13.1.e003887.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-025-11439-8","article-title":"Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review","volume":"25","author":"Daneshi","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026050807051672000_13.1.e003887.45","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-8-10","article-title":"Multidrug-resistant tuberculosis","volume":"8","author":"Zager","year":"2008","journal-title":"BMC Infect Dis"},{"key":"2026050807051672000_13.1.e003887.46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270272","article-title":"Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis","volume":"17","author":"Molla","year":"2022","journal-title":"PLoS One"},{"key":"2026050807051672000_13.1.e003887.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2010.02581.x"},{"key":"2026050807051672000_13.1.e003887.48","first-page":"1","article-title":"Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review","volume":"44","author":"Tola","year":"2015","journal-title":"Iran J Public Health"},{"key":"2026050807051672000_13.1.e003887.49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/mdr.2013.0145","article-title":"Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China","volume":"20","author":"Wang","year":"2014","journal-title":"Microb Drug Resist"},{"key":"2026050807051672000_13.1.e003887.50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/tmi.13453","article-title":"Prevalence of multidrug\u2010resistant tuberculosis in Latin America and the Caribbean: a systematic review and meta\u2010analysis","volume":"25","author":"Tengan","year":"2020","journal-title":"Tropical Med Int Health"},{"key":"2026050807051672000_13.1.e003887.51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180996","article-title":"Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis","volume":"12","author":"Onyedum","year":"2017","journal-title":"PLoS One"},{"key":"2026050807051672000_13.1.e003887.52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270003","article-title":"Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis","volume":"17","author":"Xi","year":"2022","journal-title":"PLoS One"},{"key":"2026050807051672000_13.1.e003887.53","unstructured":"WHO launches updated guidance on HIV-associated TB. Available: https:\/\/www.who.int\/news\/item\/16-05-2024-who-launches-updated-guidance-on-hiv-associated-tb [Accessed 5 Oct 2025]."},{"key":"2026050807051672000_13.1.e003887.54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266082","article-title":"Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in Eastern Cape, South Africa: A retrospective cohort study","volume":"17","author":"van de Water","year":"2022","journal-title":"PLoS One"},{"key":"2026050807051672000_13.1.e003887.55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274549","article-title":"Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa","volume":"17","author":"Nyasulu","year":"2022","journal-title":"PLoS One"},{"key":"2026050807051672000_13.1.e003887.56","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0437"},{"key":"2026050807051672000_13.1.e003887.57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.11604\/pamj.2013.14.121.2335","article-title":"Determinants of Tuberculosis treatment default in Morocco: results from a national cohort study","volume":"14","author":"Tachfouti","year":"2013","journal-title":"Pan Afr Med J"},{"key":"2026050807051672000_13.1.e003887.58","article-title":"The impact of knowledge and attitudes on adherence to tuberculosis treatment: a case-control study in a Moroccan region","volume":"12","author":"Tachfouti","year":"2012","journal-title":"Pan Afr Med J"},{"key":"2026050807051672000_13.1.e003887.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107140"},{"key":"2026050807051672000_13.1.e003887.60","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08765-0","article-title":"Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2026050807051672000_13.1.e003887.61","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268818000821"},{"key":"2026050807051672000_13.1.e003887.62","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.2147\/IDR.S524300","article-title":"Epidemiology and Molecular Drug-Resistance Patterns of Tuberculosis in Non-Elderly Patients in Luoyang, China, 2019-2023","volume":"18","author":"Wang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"2026050807051672000_13.1.e003887.63","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7104921","article-title":"Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review","volume":"2018","author":"Asgedom","year":"2018","journal-title":"J Pathog"},{"key":"2026050807051672000_13.1.e003887.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.10.004"},{"key":"2026050807051672000_13.1.e003887.65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082235","article-title":"Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis","volume":"9","author":"Mesfin","year":"2014","journal-title":"PLoS ONE"},{"key":"2026050807051672000_13.1.e003887.66","doi-asserted-by":"crossref","first-page":"102872","DOI":"10.1016\/j.tmaid.2025.102872","article-title":"Burden, clinical outcomes, and characteristics of tuberculosis in migrant populations in the middle East and North African region: A systematic review and meta-analyses","volume":"66","author":"Maatoug","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"2026050807051672000_13.1.e003887.67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/phn.12582","article-title":"Risk factors of multidrug-resistant tuberculosis in China: A meta-analysis","volume":"36","author":"Feng","year":"2019","journal-title":"Public Health Nurs"},{"key":"2026050807051672000_13.1.e003887.68","unstructured":"Mahamed OA , Hounnoukon SN , Laraqui Houssaini S , et al . Data from: Prevalence and determinants of drug-resistant pulmonary tuberculosis in the MENA region: a systematic review and meta-analysis. Zenodo 2026. doi:10.5281\/zenodo.18875562"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:06:32Z","timestamp":1778249192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,8]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjresp-2025-003887"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003887","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}